Patients and Methods Two hundred fifty-one neuroblastoma specimens were analyzed using a customized oligonucleotide microarray comprising 10,163 probes for transcripts with differential expression in ...

Oligonucleotide microarray (DNA chip)–based hybridization analysis is a promising new technology which potentially allows rapid and cost–effective screens for all possible mutations and ...

Oligonucleotide arrays were utilized to analyze the transcript profiles of 105 bladder tumors: 33 superficial, 72 invasive lesions, and 52 normal urothelium. Hierarchical clustering and supervised ...

Separately, OGT obtains rights to NimbleGen’s DNA microarrays. NimbleGen Systems licensed Oxford Gene Technology’s (OGT) Southern array patents covering the manufacture and commercialization ...

“Agilent custom microarrays have been a critical part of our success to date, and as we now move into health, wellness and disease-monitoring applications for our technology they continue to be ...

In DNA microarray analysis, there is often interest in isolating a few genes that best discriminate between tissue types. This is especially important in cancer, where different clinicopathologic ...

In releasing its DualChip microarray system, Eppendorf http://www.eppendorf.com of Hamburg, Germany, has blurred the lines between cDNA and oligonucleotide probes ...

"As combining data from multiple microarray platforms/technologies is certain to prove a common method, our results showing increased accuracy of sequence-verified probes across platforms (oligo ...